Metabolizing Enzyme Polymorphisms and Prognosis Among Women Treated for Breast Cancer
Abstract
This study will use archived tissue and data to examine survival of women treated for breast cancer in relation to inherited polymorphisms of drug metabolizing enzymes. During the first year of funding, we have completed compilation of tumor registry data for eligible subjects (Task 1 of the approved statement of work). We have also completed study start-up tasks, including IRB review, hiring study staff, creating data collection forms, establishing a study database, and training study staff on data collection procedures. Collection of tissue samples (Task 2 of the approved statement of work) has begun. Activities currently in progress include obtaining pathology slides and blocks, review of slides by the study pathologist, and abstracting information from pathology reports into the study database. As described in the statement of work, data collection tasks will continue into years 2 and 3, so no reportable scientific results are available at the end of year 1.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2002
- Accession Number
- ADA411547
Entities
People
- Carol Sweeney
Organizations
- University of Minnesota